MedTrace Logo

Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer

NCT01546363 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 95

Last updated 2020-10-05

No results posted yet for this study

Summary

The purpose of this study is to measure the levels of serum proteins and other biomarkers in cervical cancer patients. We believe that some of these markers may be useful in selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.

Conditions

Interventions

OTHER

Blood draw

phlebotomy

Sponsors & Collaborators

Principal Investigators

  • Elizabeth Kidd, MD · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-24
Primary Completion
2019-09-01
Completion
2020-06-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01546363 on ClinicalTrials.gov